H_TROP2 LLC1 Cell Line
Cat. No.
GM-C33033
Size
1 vial
Quote
Specifications
Data Display
Materials
Cell Culture
Sequence
Related products
Specifications
Cat. No GM-C33033
Product H_TROP2 LLC1 Cell Line
Description H_TROP2 LLC1 Cell Line is a clonal stable LLC1 cell line that constitutively expresses the human TROP2 gene, constructed using lentiviral technology.
Product Format 1 vials of frozen cells
Quantity 5E6 Cells per vial,1 mL
Storage Conditions Liquid nitrogen immediately upon receipt
Target Human_TROP2
Gene ID/Uniprot ID P09758(AA Met 1 - Ile 297)
Host Cell LLC1
Recovery Medium DMEM+10% FBS+1% P.S
Growth medium DMEM+10% FBS+1% P.S+1 μg/mL Puromycin
Note None
Freezing Medium 90% FBS+10% DMSO
Growth properties Mixed: adherent and suspension
Growth Conditions 37°C, 5% CO₂
Safety considerations Biosafety Level 2
Mycoplasma Testing The cell line has been screened to confirm the absence of Mycoplasma species.
Cat. No GM-C33033
Product H_TROP2 LLC1 Cell Line
Description H_TROP2 LLC1 Cell Line is a clonal stable LLC1 cell line that constitutively expresses the human TROP2 gene, constructed using lentiviral technology.
Product Format 1 vials of frozen cells
Quantity 5E6 Cells per vial,1 mL
Storage Conditions Liquid nitrogen immediately upon receipt
Target Human_TROP2
Gene ID/Uniprot ID P09758(AA Met 1 - Ile 297)
Host Cell LLC1
Recovery Medium DMEM+10% FBS+1% P.S
Growth medium DMEM+10% FBS+1% P.S+1 μg/mL Puromycin
Note None
Freezing Medium 90% FBS+10% DMSO
Growth properties Mixed: adherent and suspension
Growth Conditions 37°C, 5% CO₂
Safety considerations Biosafety Level 2
Mycoplasma Testing The cell line has been screened to confirm the absence of Mycoplasma species.
Data Display
Expression
H_TROP2 LLC1 Cell Line (Cat. GM-C33033) was determined by flow cytometry using Anti-H_TROP2 hIgG1 Antibody(datopotamab) (Cat. GM-26561AB).
Assay Performance
Tumor growth curves of H_TROP2 LLC1 in C57BL/6 mice. H_TROP2 LLC1 cells (1×10^6 per mouse) were subcutaneously inoculated into C57BL/6 mice (female, 8 weeks old, n = 2). Tumor volume was measured twice per week and is presented as mean ± SEM.
Body weight changes after implantation of H_TROP2 LLC1 in C57BL/6 mice. Under the same conditions, body weight was measured twice per week and is presented as mean ± SEM.
Materials
Reagent Ordering Information
DMEM VivaCell/C3110-0500
Fetal Bovine Serum ExCell/FSP500
Pen/Strep Thermo/15140-122
Puromycin Genomeditech/GM-040401
Anti-H_TROP2 hIgG1 Antibody(Datopotamab) Genomeditech/GM-26561AB
Reagent Ordering Information
DMEM VivaCell/C3110-0500
Fetal Bovine Serum ExCell/FSP500
Pen/Strep Thermo/15140-122
Puromycin Genomeditech/GM-040401
Anti-H_TROP2 hIgG1 Antibody(Datopotamab) Genomeditech/GM-26561AB
Cell Culture

Cell Recovery

Recovery Medium: DMEM+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: DMEM+10% FBS+1% P.S+1 μg/mL Puromycin

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)          Under normal conditions, these cells exist as both adherent and round suspension cells.

b)         When changing the medium, take care to retain the suspension cells. During passaging, collect both the adherent and suspension cells together before subculturing.

c)          Add 1.0 mL of 0.25% (w/v) Trypsin-EDTA solution to dish and observe cells under an inverted microscope until cell layer is dispersed (usually within 1 to 2 minutes at 37°C).

d)         Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

e)          Add 2.0 mL of growth medium to mix well and aspirate cells by gently pipetting.

f)          After centrifugation, resuspend the pellet and add appropriate aliquots of the cell suspension to new culture vessels.

g)         Incubate cultures at 37°C.

Subcultivation Ratio: A subcultivation ratio of 1:2 - 1:4 is recommended

Medium Renewal: Every 2 to 3 days

Notes

a)          After the stabilization of the cell condition, there will be fewer dead cells post-passage, the cell growth rate will tend to stabilize, cell morphology will become uniform, and the cells will appear robust.

 

Cell Recovery

Recovery Medium: DMEM+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: DMEM+10% FBS+1% P.S+1 μg/mL Puromycin

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)          Under normal conditions, these cells exist as both adherent and round suspension cells.

b)         When changing the medium, take care to retain the suspension cells. During passaging, collect both the adherent and suspension cells together before subculturing.

c)          Add 1.0 mL of 0.25% (w/v) Trypsin-EDTA solution to dish and observe cells under an inverted microscope until cell layer is dispersed (usually within 1 to 2 minutes at 37°C).

d)         Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

e)          Add 2.0 mL of growth medium to mix well and aspirate cells by gently pipetting.

f)          After centrifugation, resuspend the pellet and add appropriate aliquots of the cell suspension to new culture vessels.

g)         Incubate cultures at 37°C.

Subcultivation Ratio: A subcultivation ratio of 1:2 - 1:4 is recommended

Medium Renewal: Every 2 to 3 days

Notes

a)          After the stabilization of the cell condition, there will be fewer dead cells post-passage, the cell growth rate will tend to stabilize, cell morphology will become uniform, and the cells will appear robust.

 

Sequence

  TROP2(ΔICD) P09758MARGPGLAPPPLRLPLLLLVLAAVTGHTAAQDNCTCPTNKMTVCSPDGPGGRCQCRALGSGMAVDCSTLTSKCLLLKARMSAPKNARTLVRPSEHALVDNDGLYDPDCDPEGRFKARQCNQTSVCWCVNSVGVRRTDKGDLSLRCDELVRTHHILIDLRHRPTAGAFNHSDLDAELRRLFRERYRLHPKFVAAVHYEQPTIQIELRQNTSQKAAGDVDIGDAAYYFERDIKGESLFQGRGGLDLRVRGEPLQVERTLIYYLDEIPPKFSMKRLTAGLIAVIVVVVVALVAGMAVLVI*

  TROP2(ΔICD) P09758MARGPGLAPPPLRLPLLLLVLAAVTGHTAAQDNCTCPTNKMTVCSPDGPGGRCQCRALGSGMAVDCSTLTSKCLLLKARMSAPKNARTLVRPSEHALVDNDGLYDPDCDPEGRFKARQCNQTSVCWCVNSVGVRRTDKGDLSLRCDELVRTHHILIDLRHRPTAGAFNHSDLDAELRRLFRERYRLHPKFVAAVHYEQPTIQIELRQNTSQKAAGDVDIGDAAYYFERDIKGESLFQGRGGLDLRVRGEPLQVERTLIYYLDEIPPKFSMKRLTAGLIAVIVVVVVALVAGMAVLVI*

Related products
CLDN18
Cynomolgus_CLDN18.2-eGFP CHO-K1 Cell Line H_CLDN18(isoform2)-eGFP 293 Cell Line H_CLDN18.1-eGFP HEK-293 Cell Line
H_CLDN18.2 MC38 Cell Line H_CLDN18.2 MKN45 Cell Line(High Expression) H_CLDN18.2 MKN45 Cell Line(Low Expression)
H_CLDN18.2 MKN45 Cell Line(Medium Expression) H_CLDN18.2(isoform2) CHO-K1 Cell Line H_CLDN18.2-eGFP CT-26 Cell Line
Mouse_CLDN18.2-eGFP CHO-K1 Cell Line Rat_CLDN18.2-eGFP CHO-K1 Cell Line Rhesus_CLDN18.2-eGFP CHO-K1 Cell Line
Anti-CLDN18.2 hIgG1 Reference Antibody (IMAB362) Anti-CLDN18.2 hIgG1 Antibody(LM-102) Anti-CLDN18.2 hIgG1 Antibody(Zolbetuximab)
C-MET:HGF
H_cMET KO HEK-293 Cell Line H_cMET: cMET Dimerization U2OS Cell Line Cynomolgus_cMET CHO-K1 Cell Line
H_cMET CHO-K1 Cell Line H_cMET HEK-293 Cell Line H_cMET HEK-293(cMET KO) Cell Line
Anti-H_HGFR(Met) hIgG4 Antibody(Emibetuzumab) Anti-HGFR(Met) hIgG1 Reference Antibody (Telibio)
Human HGFR(Met) Protein; His Tag    
CD276(B7H3)
Cynomolgus_CD276 CHO-K1 Cell Line H_CD276(B7H3) CHO-K1 Cell Line
Anti-CD276(B7H3) hIgG1 Reference Antibody(Ifibio) Anti-CD276(B7H3)-DXD (Dar4)[Ifinatamab deruxtecan]
Biotinylated Human CD276(B7H3 2Ig) Protein; His-Avi Tag Biotinylated Human CD276(B7H3 4Ig) Protein; His-Avi Tag Cynomolgus CD276(B7H3 4Ig) Protein; His Tag
Human CD276(B7H3 2Ig) Protein; hFc Tag Human CD276(B7H3 2Ig) Protein; His Tag Human CD276(B7H3 4Ig) Protein; His Tag
TROP2(TACSTD2)
Cynomolgus_Trop2 CHO-K1 Cell Line Cynomolgus_TROP2 HEK-293 Cell Line H_TROP2 CHO-K1 Cell Line
H_TROP2 CT26 Cell Line H_TROP2 HEK-293 Cell Line
Anti-H_TROP2 hIgG1 Antibody(Datopotamab) Anti-TROP2 hIgG1 Antibody(Hu2G10-5) Anti-Trop2 hIgG1 Reference Antibody (Sacbio)
Anti-Trop2 hIgG1 Reference Antibody(Datbio) Anti-Trop2-DXD ADC(Dar4)[Datopotamab deruxtecan,Dato-DXD] Anti-Trop2-SN38 ADC(Dar8)[Sacituzumab govitecan]
Biotinylated Cynomolgus TROP2 Protein; His-Avi Tag Biotinylated Human TROP2 Protein; His-Avi Tag Human TROP2 Protein; His Tag
GUCY2C(GC-C)
Cynomolgus_GUCY2C HEK-293 Cell Line H_GUCY2C CHO-K1 Cell Line H_GUCY2C HEK-293 Cell Line
Anti-H_GUCY2C hIgG1 Antibody(Indusatumab)
Human GUCY2C Protein; His Tag    
FGFR2
H_FGFR2b Reporter 293 Cell Line Cynomolgus_FGFR2b HEK-293 Cell Line H_FGFR2b CHO-K1 Cell Line
H_FGFR2b HEK-293 Cell Line Mouse_FGFR2b HEK-293 Cell Line
Anti-FGFR2 hIgG1 Antibody(hFR2-14_H12-L1) Anti-FGFR2 hIgG1 Referece Antibody (Bemabio)
Cynomolgus FGFR2(IIIb) D1-D3 Protein; His Tag Human FGFR2(IIIb) D1-D3 Protein; hFc Tag Human FGFR2(IIIb) D2-D3 Protein; hFc Tag
Human FGFR2(IIIb) D2-D3 Protein; His Tag Human FGFR2(IIIc) D1-D3 Protein; His Tag Mouse FGFR2(IIIb) D2-D3 Protein; His Tag
CD44
H_CD44s CHO-K1 Cell Line H_CD44v6 CHO-K1 Cell Line H_CD44v6 CHO-K1 Cell Line (Medium Expression)
H_CD44v6 HEK-293 Cell Line
Anti-CD44v6 hIgG1 Antibody(bivatuzumab)    
ADC Related Product
Anti-DXD Mouse IgG1 Antibody (23E21C5) Anti-DXD Mouse IgG1 Antibody (4A5A12) Anti-Dxd Mouse IgG2a Antibody (17D6A4)
Anti-Eribulin Mouse IgG2a Antibody (10F8G4) Anti-MMAE Mouse IgG1 Antibody (11C10E3) Anti-MMAE Mouse IgG2a Antibody (17A1K11)
Anti-MMAE Mouse IgG2a Antibody (8F6A3) Anti-SN38 Mouse IgG1 Antibody(59H11C7) Mouse anti Human IgG1-DXD(Dar8)
Mouse anti Human IgG1-MMAE(Dar4) Human IgG1 Isotype-DXD (Dar8) Human IgG1 Isotype-Eribulin (Dar4)
Human IgG1 Isotype-MMAE (Dar4)
Recombinant DT3C Protein    
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.
H_TROP2 LLC1 Cell Line
Cat. No.
GM-C33033
Size
1 vial
Quote
Specifications
Data Display
Materials
Cell Culture
Sequence
Related products
Specifications
Cat. No GM-C33033
Product H_TROP2 LLC1 Cell Line
Description H_TROP2 LLC1 Cell Line is a clonal stable LLC1 cell line that constitutively expresses the human TROP2 gene, constructed using lentiviral technology.
Product Format 1 vials of frozen cells
Quantity 5E6 Cells per vial,1 mL
Storage Conditions Liquid nitrogen immediately upon receipt
Target Human_TROP2
Gene ID/Uniprot ID P09758(AA Met 1 - Ile 297)
Host Cell LLC1
Recovery Medium DMEM+10% FBS+1% P.S
Growth medium DMEM+10% FBS+1% P.S+1 μg/mL Puromycin
Note None
Freezing Medium 90% FBS+10% DMSO
Growth properties Mixed: adherent and suspension
Growth Conditions 37°C, 5% CO₂
Safety considerations Biosafety Level 2
Mycoplasma Testing The cell line has been screened to confirm the absence of Mycoplasma species.
Cat. No GM-C33033
Product H_TROP2 LLC1 Cell Line
Description H_TROP2 LLC1 Cell Line is a clonal stable LLC1 cell line that constitutively expresses the human TROP2 gene, constructed using lentiviral technology.
Product Format 1 vials of frozen cells
Quantity 5E6 Cells per vial,1 mL
Storage Conditions Liquid nitrogen immediately upon receipt
Target Human_TROP2
Gene ID/Uniprot ID P09758(AA Met 1 - Ile 297)
Host Cell LLC1
Recovery Medium DMEM+10% FBS+1% P.S
Growth medium DMEM+10% FBS+1% P.S+1 μg/mL Puromycin
Note None
Freezing Medium 90% FBS+10% DMSO
Growth properties Mixed: adherent and suspension
Growth Conditions 37°C, 5% CO₂
Safety considerations Biosafety Level 2
Mycoplasma Testing The cell line has been screened to confirm the absence of Mycoplasma species.
Data Display
Expression
H_TROP2 LLC1 Cell Line (Cat. GM-C33033) was determined by flow cytometry using Anti-H_TROP2 hIgG1 Antibody(datopotamab) (Cat. GM-26561AB).
Assay Performance
Tumor growth curves of H_TROP2 LLC1 in C57BL/6 mice. H_TROP2 LLC1 cells (1×10^6 per mouse) were subcutaneously inoculated into C57BL/6 mice (female, 8 weeks old, n = 2). Tumor volume was measured twice per week and is presented as mean ± SEM.
Body weight changes after implantation of H_TROP2 LLC1 in C57BL/6 mice. Under the same conditions, body weight was measured twice per week and is presented as mean ± SEM.
Materials
Reagent Ordering Information
DMEM VivaCell/C3110-0500
Fetal Bovine Serum ExCell/FSP500
Pen/Strep Thermo/15140-122
Puromycin Genomeditech/GM-040401
Anti-H_TROP2 hIgG1 Antibody(Datopotamab) Genomeditech/GM-26561AB
Reagent Ordering Information
DMEM VivaCell/C3110-0500
Fetal Bovine Serum ExCell/FSP500
Pen/Strep Thermo/15140-122
Puromycin Genomeditech/GM-040401
Anti-H_TROP2 hIgG1 Antibody(Datopotamab) Genomeditech/GM-26561AB
Cell Culture

Cell Recovery

Recovery Medium: DMEM+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: DMEM+10% FBS+1% P.S+1 μg/mL Puromycin

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)          Under normal conditions, these cells exist as both adherent and round suspension cells.

b)         When changing the medium, take care to retain the suspension cells. During passaging, collect both the adherent and suspension cells together before subculturing.

c)          Add 1.0 mL of 0.25% (w/v) Trypsin-EDTA solution to dish and observe cells under an inverted microscope until cell layer is dispersed (usually within 1 to 2 minutes at 37°C).

d)         Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

e)          Add 2.0 mL of growth medium to mix well and aspirate cells by gently pipetting.

f)          After centrifugation, resuspend the pellet and add appropriate aliquots of the cell suspension to new culture vessels.

g)         Incubate cultures at 37°C.

Subcultivation Ratio: A subcultivation ratio of 1:2 - 1:4 is recommended

Medium Renewal: Every 2 to 3 days

Notes

a)          After the stabilization of the cell condition, there will be fewer dead cells post-passage, the cell growth rate will tend to stabilize, cell morphology will become uniform, and the cells will appear robust.

 

Cell Recovery

Recovery Medium: DMEM+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: DMEM+10% FBS+1% P.S+1 μg/mL Puromycin

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)          Under normal conditions, these cells exist as both adherent and round suspension cells.

b)         When changing the medium, take care to retain the suspension cells. During passaging, collect both the adherent and suspension cells together before subculturing.

c)          Add 1.0 mL of 0.25% (w/v) Trypsin-EDTA solution to dish and observe cells under an inverted microscope until cell layer is dispersed (usually within 1 to 2 minutes at 37°C).

d)         Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

e)          Add 2.0 mL of growth medium to mix well and aspirate cells by gently pipetting.

f)          After centrifugation, resuspend the pellet and add appropriate aliquots of the cell suspension to new culture vessels.

g)         Incubate cultures at 37°C.

Subcultivation Ratio: A subcultivation ratio of 1:2 - 1:4 is recommended

Medium Renewal: Every 2 to 3 days

Notes

a)          After the stabilization of the cell condition, there will be fewer dead cells post-passage, the cell growth rate will tend to stabilize, cell morphology will become uniform, and the cells will appear robust.

 

 

Sequence

  TROP2(ΔICD) P09758MARGPGLAPPPLRLPLLLLVLAAVTGHTAAQDNCTCPTNKMTVCSPDGPGGRCQCRALGSGMAVDCSTLTSKCLLLKARMSAPKNARTLVRPSEHALVDNDGLYDPDCDPEGRFKARQCNQTSVCWCVNSVGVRRTDKGDLSLRCDELVRTHHILIDLRHRPTAGAFNHSDLDAELRRLFRERYRLHPKFVAAVHYEQPTIQIELRQNTSQKAAGDVDIGDAAYYFERDIKGESLFQGRGGLDLRVRGEPLQVERTLIYYLDEIPPKFSMKRLTAGLIAVIVVVVVALVAGMAVLVI*

  TROP2(ΔICD) P09758MARGPGLAPPPLRLPLLLLVLAAVTGHTAAQDNCTCPTNKMTVCSPDGPGGRCQCRALGSGMAVDCSTLTSKCLLLKARMSAPKNARTLVRPSEHALVDNDGLYDPDCDPEGRFKARQCNQTSVCWCVNSVGVRRTDKGDLSLRCDELVRTHHILIDLRHRPTAGAFNHSDLDAELRRLFRERYRLHPKFVAAVHYEQPTIQIELRQNTSQKAAGDVDIGDAAYYFERDIKGESLFQGRGGLDLRVRGEPLQVERTLIYYLDEIPPKFSMKRLTAGLIAVIVVVVVALVAGMAVLVI*

Related products
CLDN18
Cynomolgus_CLDN18.2-eGFP CHO-K1 Cell Line H_CLDN18(isoform2)-eGFP 293 Cell Line H_CLDN18.1-eGFP HEK-293 Cell Line
H_CLDN18.2 MC38 Cell Line H_CLDN18.2 MKN45 Cell Line(High Expression) H_CLDN18.2 MKN45 Cell Line(Low Expression)
H_CLDN18.2 MKN45 Cell Line(Medium Expression) H_CLDN18.2(isoform2) CHO-K1 Cell Line H_CLDN18.2-eGFP CT-26 Cell Line
Mouse_CLDN18.2-eGFP CHO-K1 Cell Line Rat_CLDN18.2-eGFP CHO-K1 Cell Line Rhesus_CLDN18.2-eGFP CHO-K1 Cell Line
Anti-CLDN18.2 hIgG1 Reference Antibody (IMAB362) Anti-CLDN18.2 hIgG1 Antibody(LM-102) Anti-CLDN18.2 hIgG1 Antibody(Zolbetuximab)
C-MET:HGF
H_cMET KO HEK-293 Cell Line H_cMET: cMET Dimerization U2OS Cell Line Cynomolgus_cMET CHO-K1 Cell Line
H_cMET CHO-K1 Cell Line H_cMET HEK-293 Cell Line H_cMET HEK-293(cMET KO) Cell Line
Anti-H_HGFR(Met) hIgG4 Antibody(Emibetuzumab) Anti-HGFR(Met) hIgG1 Reference Antibody (Telibio)
Human HGFR(Met) Protein; His Tag    
CD276(B7H3)
Cynomolgus_CD276 CHO-K1 Cell Line H_CD276(B7H3) CHO-K1 Cell Line
Anti-CD276(B7H3) hIgG1 Reference Antibody(Ifibio) Anti-CD276(B7H3)-DXD (Dar4)[Ifinatamab deruxtecan]
Biotinylated Human CD276(B7H3 2Ig) Protein; His-Avi Tag Biotinylated Human CD276(B7H3 4Ig) Protein; His-Avi Tag Cynomolgus CD276(B7H3 4Ig) Protein; His Tag
Human CD276(B7H3 2Ig) Protein; hFc Tag Human CD276(B7H3 2Ig) Protein; His Tag Human CD276(B7H3 4Ig) Protein; His Tag
TROP2(TACSTD2)
Cynomolgus_Trop2 CHO-K1 Cell Line Cynomolgus_TROP2 HEK-293 Cell Line H_TROP2 CHO-K1 Cell Line
H_TROP2 CT26 Cell Line H_TROP2 HEK-293 Cell Line
Anti-H_TROP2 hIgG1 Antibody(Datopotamab) Anti-TROP2 hIgG1 Antibody(Hu2G10-5) Anti-Trop2 hIgG1 Reference Antibody (Sacbio)
Anti-Trop2 hIgG1 Reference Antibody(Datbio) Anti-Trop2-DXD ADC(Dar4)[Datopotamab deruxtecan,Dato-DXD] Anti-Trop2-SN38 ADC(Dar8)[Sacituzumab govitecan]
Biotinylated Cynomolgus TROP2 Protein; His-Avi Tag Biotinylated Human TROP2 Protein; His-Avi Tag Human TROP2 Protein; His Tag
GUCY2C(GC-C)
Cynomolgus_GUCY2C HEK-293 Cell Line H_GUCY2C CHO-K1 Cell Line H_GUCY2C HEK-293 Cell Line
Anti-H_GUCY2C hIgG1 Antibody(Indusatumab)
Human GUCY2C Protein; His Tag    
FGFR2
H_FGFR2b Reporter 293 Cell Line Cynomolgus_FGFR2b HEK-293 Cell Line H_FGFR2b CHO-K1 Cell Line
H_FGFR2b HEK-293 Cell Line Mouse_FGFR2b HEK-293 Cell Line
Anti-FGFR2 hIgG1 Antibody(hFR2-14_H12-L1) Anti-FGFR2 hIgG1 Referece Antibody (Bemabio)
Cynomolgus FGFR2(IIIb) D1-D3 Protein; His Tag Human FGFR2(IIIb) D1-D3 Protein; hFc Tag Human FGFR2(IIIb) D2-D3 Protein; hFc Tag
Human FGFR2(IIIb) D2-D3 Protein; His Tag Human FGFR2(IIIc) D1-D3 Protein; His Tag Mouse FGFR2(IIIb) D2-D3 Protein; His Tag
CD44
H_CD44s CHO-K1 Cell Line H_CD44v6 CHO-K1 Cell Line H_CD44v6 CHO-K1 Cell Line (Medium Expression)
H_CD44v6 HEK-293 Cell Line
Anti-CD44v6 hIgG1 Antibody(bivatuzumab)    
ADC Related Product
Anti-DXD Mouse IgG1 Antibody (23E21C5) Anti-DXD Mouse IgG1 Antibody (4A5A12) Anti-Dxd Mouse IgG2a Antibody (17D6A4)
Anti-Eribulin Mouse IgG2a Antibody (10F8G4) Anti-MMAE Mouse IgG1 Antibody (11C10E3) Anti-MMAE Mouse IgG2a Antibody (17A1K11)
Anti-MMAE Mouse IgG2a Antibody (8F6A3) Anti-SN38 Mouse IgG1 Antibody(59H11C7) Mouse anti Human IgG1-DXD(Dar8)
Mouse anti Human IgG1-MMAE(Dar4) Human IgG1 Isotype-DXD (Dar8) Human IgG1 Isotype-Eribulin (Dar4)
Human IgG1 Isotype-MMAE (Dar4)
Recombinant DT3C Protein    
Message consultation
reset
submit
Message
Message consultation
reset
submit